Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: integrin receptor antagonists - Johnson & Johnson Pharmaceutical Research and Development, LLC

Next Previous
X
Search
Drug Profile

Research programme: integrin receptor antagonists - Johnson & Johnson Pharmaceutical Research and Development, LLC

Alternative Names: 3DP-229300; 3DP-336036

Latest Information Update: 06 Mar 2008

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Johnson & Johnson Pharmaceutical Research & Development
  • Developer Johnson & Johnson Pharmaceutical Research & Development LLC
  • Class Hydroxyquinolines; Propionic acids; Small molecules
  • Mechanism of Action Angiogenesis inhibitors; Integrin alphaVbeta3 antagonists; Integrin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Cardiovascular disorders

Most Recent Events

  • 10 Sep 2004 Data presented at the 228th American Chemical Society National Meeting (228th-ACS-2004) have been added to the pharmacokinetics and Cancer pharmacodynamics sections ,
  • 02 Aug 2004 A preclinical study has been added to the Cancer pharmacodynamics section
  • 16 Apr 2003 3-Dimensional Pharmaceuticals has been acquired by Johnson & Johnson

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top